Sofosbuvir + velpatasvir + voxilaprevir for the treatment of hepatitis C infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sofosbuvir + velpatasvir + voxilaprevir for the treatment of hepatitis C infection

Published:2018-04-10 Issue:7 Volume:19 Page:749-757
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Cory Theodore J.¹,Mu Ying¹,Gong Yuqing²,Kodidela Sunitha²,Kumar Santosh²

Affiliation:

1. Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center College of Pharmacy, Memphis, TN, USA

2. Department of Pharmaceutical Sciences, University of Tennessee Health Science Center College of Pharmacy, Memphis, TN, USA

Funder

National Institute on Alcohol Abuse and Alcoholism

National Institute on Drug Abuse

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2018.1459567

Reference34 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

2. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle

3. Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options

4. NS5A inhibitors in the treatment of hepatitis C

5. Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV;JHEP Reports;2023-11

2. Hepatitis C: A Pharmacological Therapeutic Update;Journal of Clinical Medicine;2021-04-08

3. Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection;Frontiers in Microbiology;2021-01-28

4. In-Vitro and In-Vivo Evaluation of Velpatasvir- Loaded Mesoporous Silica Scaffolds. A Prospective Carrier for Drug Bioavailability Enhancement;Pharmaceutics;2020-03-28

5. Synthetic Approaches to Contemporary Drugs that Contain the Cyclopropyl Moiety;Synthesis;2020-03-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3